Innate Pharma SA (IPHA)
1.743
-0.02
(-0.97%)
USD |
NASDAQ |
Jan 16, 16:00
1.76
+0.02
(+0.98%)
After-Hours: 20:00
Innate Pharma Market Cap: 163.32M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| DBV Technologies SA | 568.58M |
| Cellectis SA | 408.32M |
| Inventiva SA | 949.55M |
| Nanobiotix SA | 1.016B |
| Valneva SE | 856.27M |
Market Cap Related Metrics
| PS Ratio | 22.51 |
| Price | 1.743 |
| Earnings Yield | -34.27% |